Release Notes Medtech Evolution General Practice

Transcription

1 Release Notes Medtech Evolution General Practice Version 1.9 Build (June 2017) These release notes contain important information for Medtech Evolution users. Please ensure that they are circulated among all relevant staff. We suggest that they are filed safely for future reference. Copyright Medtech Limited Page 1 of 26

2 Table of Contents Introduction 4 NEW ENHANCEMENTS 4 Changes to the National Immunisation Schedule July New 2017 Immunisation Schedules 6 SETUP OF 2017 IMMUNISATION SCHEDULES 6 IMMUNISATION SCHEDULES FOR TRANSITIONING PATIENTS FROM THE 2014 IMMUNISATION SCHEDULE 8 Rotavirus Monovalent Vaccination 11 NEW ROTAVIRUS MONOVALENT VACCINE 11 Pneumococcal Vaccination 12 CHANGES TO PNEUMOCOCCAL VACCINATION 12 Varicella Vaccination 13 NEW VARICELLA VACCINES 13 HPV9 Vaccination 15 INCLUDING HPV9 VACCINES WITHIN CHILDHOOD IMMUNISATION SCHEDULE 15 New High Risk Vaccinations 18 SETUP OF HIGH RISK VACCINES 18 NEW HIGH RISK VACCINES 18 Increase in Dosage Interval between 23PPV Vaccines 22 CHANGES TO 23PPV VACCINE-CONTAINING SCHEDULES 22 Changes to Valid Alternatives of Tdap-11y Vaccine 24 ADDITION OF NEW VALID ALTERNATIVE VACCINE FOR TDAP-11Y 24 MESSAGING OF ALL VALID ALTERNATIVES OF TDAP-11Y VACCINE TO NIR 25 General Changes 26 MEDTECH EVOLUTION IMMUNISATION AUDIT REPORT 26 NIR IMMUNISATION AUDIT REPORT 26 Copyright Medtech Limited Page 2 of 26

3 IMMUNISATION MERGE FIELD 26 OUTBOX DOCUMENT WIZARD 26 PROVIDER INBOX VACCINE UPDATE MESSAGES 26 Copyright Medtech Limited Page 3 of 26

4 Introduction These release notes provide an overview of the enhancements made within Medtech Evolution Version 1.9 Build to support the new NIR schedule changes that will come into effect from 1 July New Enhancements Description of Change Category Impact The following changes have been made in Medtech Evolution to support the Ministry of Health s requirements for the July 2017 NIR Schedule changes: Creation of a new Childhood Immunisation Schedule for 2017 Creation of new Catch-Up schedules for 2017 Creation of a new Baby of Hepatitis B Mother schedule for 2017 Pneumococcal 10-valent protein conjugate vaccine (PCV10) has replaced the pneumococcal 13-valent protein conjugate vaccine (PCV13) in the Childhood Immunisation Schedule for 2017 Rotavirus monovalent vaccine has replaced the Rotavirus pentavalent vaccine. This new vaccine must be given at 6 weeks and 3 months only; a third vaccination at 5 months is no longer required. Varicella vaccine has been added to the Childhood Immunisation Schedule for 2017, with a single dose to be given at 15 months A standalone Varicella vaccine has been included to be given at 11 years of age, if the patient has never had a Varicella infection or has not previously received the Varicella vaccine HPV9 vaccines have been introduced under the Childhood Immunisation Schedule for 2017 New High Risk vaccines have been created for the following: PCV13, Hib, Meningococcal B, Hepatitis B (Paed/Adol), Hepatitis B (Adult) The interval between the two 23 PPV vaccine doses has been increased from 3 years to 5 years Ensure that all alternative vaccines to Tdap-11 years are being sent to NIR Regulatory Major Copyright Medtech Limited Page 4 of 26

5 Changes to the National Immunisation Schedule July 2017 EMPOWERING HEALTH The Ministry of Health has confirmed the following changes to the National Immunisation Schedule, effective from 1 July The 13-valent pneumococcal vaccine [Prevenar 13; PCV13] will be replaced by the 10-valent PCV10 vaccine [Synflorix]. Prevenar 13 (PCV13) will remain available for high-risk patients only. Under the Childhood Immunisation Schedule, the three-dose rotavirus pentavalent vaccine [RotaTeq] schedule will be replaced by a two-dose rotavirus monovalent vaccine [Rotarix] schedule, except where a patient has started the rotavirus pentavalent vaccine schedule. In this scenario, the patient will be able to complete their original three-dose regimen with Rotarix (monovalent) or, while stocks remain, with RotaTeq (pentavalent). Funded access to the Varicella vaccine (Varilrix) will be widened to include one dose for primary vaccination in children at 15 months, and for previously unvaccinated children turning 11 years on or after 1 July 2017 who have not had a previous Varicella (chickenpox) infection. From 1 July 2017, the Human Papillomavirus 9 valent Vaccine (HPV9) will be scheduled within the Childhood Immunisation Schedule in Medtech Evolution and not as a standalone HPV schedule. New High Risk vaccines will be messaged to NIR. The new high-risk vaccines are Hib, PCV13, Meningococcal B, Hepatitis B (Adol/Paed) and Hepatitis B (Adult). Increase in the dosage interval period between 23PPV Dose 1 and 23PPV Dose 2 from three years to five years. Ensuring that there are no messaging restrictions (like Birth Cohort rules) for any valid alternative to the Tdap-11y vaccine. Copyright Medtech Limited Page 5 of 26

6 New 2017 Immunisation Schedules EMPOWERING HEALTH Setup of 2017 Immunisation Schedules File Options Recall Screening Immunisation Schedule The following new schedules have been added to Medtech Evolution for the 2017 Immunisation Schedule changes: New Schedules Schedule Details Childhood Immunisation Schedule Childhood Immunisation Schedule 2017 Hepatitis B Schedule Baby of HepB Positive Mother 2017 Catch-Up Schedules Std CU wks 1st dose 2017 Std CU 15 wks-6 mths 1st dose 2017 Std CU 7-11 mths 1st dose 2017 Std CU mths 1st dose 2017 Std CU mths 1st dose 2017 Std CU mths 1st dose 2017 Std CU 5-9yrs 1st dose 2017 Std CU yrs 1st Dose 2017 Std CU 18+ yrs 1st Dose 2017 Std CU yrs 1st dose (HPV9 only) 2017 Std CU yrs 1st dose (HPV9 only) 2017 Please note: the Catch-Up schedules will not have dose of the HPV9 vaccine available as part of the scheduled 11 year vaccination tasks. Instead there are two separate HPV9 Catch-Up schedules for the age groups of years and years; these can be used based on the patient s age at the time of vaccination. Copyright Medtech Limited Page 6 of 26

7 Immunisation Schedules for 2017 Patient Immunisations The new 2017 Immunisation Schedules replace the current 2014 Immunisation Schedules and will be available for selection under the Schedule Selection tab of the Immunisation module. All the new schedules include tasks for the new rotavirus monovalent vaccine (at ages 6W & 3M), Varicella vaccine (at age 15M) and HPV9 vaccine (at age 11Y). The PCV13 vaccine has been replaced with PCV10 (at ages 6W, 3M, 5M & 15M). Copyright Medtech Limited Page 7 of 26

8 Transitioning patients from the 2014 Immunisation Schedule Children aged less than 6 weeks (5 weeks and 6 days) on 1 July 2017 will be added to the new Childhood Immunisation Schedule for Children who are due or overdue for their 6W, 3M, 5M or 15M immunisations (under the Childhood Immunisation Schedule 2014) on or after 1 July 2017 will be transferred to the new Childhood Immunisation Schedule for This will enable them to receive the new rotavirus monovalent, PCV10 and Varicella vaccines. After moving to the new 2017 Childhood Immunisation schedule, the following changes will be noted: If the child has received PCV13 vaccination under the 2014 schedule, then on transferring to the new 2017 schedule, vaccination with the PCV10 vaccine under the new schedule will be updated with the Alternative Given outcome. If the child has received the DTaP-IPV-HepB/Hib vaccine under the 2014 schedule, then on transferring to the new 2017 schedule, the DTaP-IPV-HepB/Hib vaccine in the new schedule will be updated with the Given outcome. All vaccines received under the 2014 schedule will be displayed under the All Immunisation tab. Copyright Medtech Limited Page 8 of 26

9 There are special transition rules for the rotavirus vaccines and these are given below: Number of Rotavirus Pentavalent doses received under 2014 Schedule Number of Rotavirus Monovalent doses required in New Schedule 3 Rotavirus pentavalent doses No Rotavirus monovalent doses required 2 Rotavirus pentavalent doses (i.e. received doses at 6W & 3M, did not receive third dose at 5M) 1 Rotavirus pentavalent dose (i.e. received 1 dose at 6W, did not receive the second and third doses at 3M & 5M) a. According to the Ministry of Health, one dose of the Rotavirus monovalent vaccine must be given to the patient; the interval between this dose and the second Rotavirus pentavalent dose (given under the 2014 schedule) must be more than 4 weeks. The Rotavirus mono, Dose 2 vaccine will be given to the patient under the 5 months schedule. b. The Rotavirus mono, Dose 1 under the CI 2017 schedule will be automatically updated with the status of Alternative Given and will be displayed under the 6 weeks schedule. c. If the patient s age is older than 24 weeks and 6 days, and the Rotavirus mono, Dose 2 has not been given, then this vaccine will be automatically closed-off with the status of Closed Not Required (Rotavirus mono, Dose 1 will have the status of Alternative Given ) a. According to the Ministry of Health, two doses of the Rotavirus monovalent vaccine doses must be given to the patient. A minimum gap of at least 4 weeks must be maintained between the two doses. b. The patient will receive Rotavirus mono, Dose 1 under the 3 months schedule. c. Rotavirus mono, Dose 2 will be administered under the 5 months schedule. d. If the patient s age is greater than 24 weeks and 6 days, and the Rotavirus mono, Dose 1 and Rotavirus mono, Dose 2 have not been given, then these vaccines will be automatically closed-off with the status of Closed Not Required The screenshot given below displays the transition of a patient from 2014 to 2017 Childhood Immunisation Schedule who have immunisations due under the 3M, 5M and 15M groups. Copyright Medtech Limited Page 9 of 26

10 Similarly the screenshot given below displays the transition of a patient from 2014 to 2017 Childhood Immunisation Schedule who have immunisations due under the 5M and 15M groups. Please note: there will be a Transition Utility available in the Medtech Evolution Version 1.9 Build After installing this build, the transition utility will be triggered when the first user at the practice logs into Medtech Evolution on or after 1 July Copyright Medtech Limited Page 10 of 26

11 Rotavirus Monovalent Vaccination New Rotavirus Monovalent Vaccine EMPOWERING HEALTH File Options Recall Screening Vaccine Patient Immunisations A new Rotavirus vaccine has been added under the 2017 Immunisation Schedules. This vaccine will be available under the scheduled 6-week and 3-month vaccination tasks. Vaccine Codes ROTAM1 ROTAM2 Vaccine Names Rotavirus mono, Dose1 Rotavirus mono, Dose2 The child will not be able to receive their first dose of the rotavirus monovalent vaccine if they are older than 14 weeks and 6 days. If the child is older than 14 weeks and 6 days and they have not received their first dose of the vaccine, then the incomplete Rotavirus vaccination tasks (both 1 st and 2 nd doses) will be updated automatically with the Outcome status of Closed Not Required. Similarly, both the Rotavirus Monovalent vaccination tasks must be completed by the age of 24 weeks and 6 days. If the child is older than 24 weeks and 6 days and they have not completed the Rotavirus vaccination tasks (second dose not yet given), then the incomplete Rotavirus vaccination task will be automatically updated with the Outcome status of Closed Not Required. Copyright Medtech Limited Page 11 of 26

12 Pneumococcal Vaccination Changes to Pneumococcal Vaccination File Options Recall Screening Vaccine Patient Immunisations Under the 2014 schedules, the PCV13 vaccine was available for administration to children at age 6W, 3M, 5M and 15M. This vaccine has been replaced with the PCV10 vaccine in all immunisation schedules for Vaccine Codes PC10-1 PC10-2 PC10-3 PC10-4 Vaccine Names Pneum, conj 10, 6w Pneum, conj 10, 3m Pneum, conj 10, 5m Pneum, conj 10, 15m The change from PCV13 to PCV10 vaccination is only for the 2017 Childhood Immunisation Schedule, Catch-Up schedules and Baby of Hep B Mother schedules. Please note: the PCV13 vaccine will not be replaced with PCV10 vaccine under the 2014 Pneumococcal Schedules. The PCV13 vaccine will still be available as a valid alternative to the new PCV10 vaccine. Copyright Medtech Limited Page 12 of 26

13 Varicella Vaccination New Varicella Vaccines File Options Recall Screening Vaccine Patient Immunisations A new Varicella vaccine has been added under the 2017 Childhood Immunisation Schedule. From 1 July 2017 all individuals born on or after 1 April 2016 are eligible to receive the Varicella vaccine, which will be available under the 15-month vaccination tasks. Vaccine Codes VAR15M VAR11Y Vaccine Names Varicella 15m Varicella 11y Children who are due or overdue for their 15-month vaccination tasks under the 2014 schedule will be transitioned into the 2017 Childhood Immunisation Schedule so that they will receive the Varicella 15-month vaccination task. The Varicella vaccine (Varicella 11y) can be administered to 11 years old outside of the Childhood Immunisation Schedule, via the Single Syringe icon under the Immunisation Schedule tab and the All Immunisations tab. However, this is restricted to previously unvaccinated children turning 11 years old on or after 1 July 2017 who have not had a previous Varicella infection (chickenpox). Copyright Medtech Limited Page 13 of 26

14 Copyright Medtech Limited Page 14 of 26

15 HPV9 Vaccination Including HPV9 Vaccines within Childhood Immunisation Schedule Patient Immunisations From 1 July 2017, the HPV9 vaccination tasks (for children aged years) will be scheduled within the Childhood Immunisation programme in Medtech Evolution and not as a standalone HPV9 Vaccine programme. By default, the schedule will have three doses of the HPV9 vaccine with the first vaccine scheduled when the child is aged 11 years. The schedule dosage intervals are as follows: HPV9 Dose 1 (at age 11 years) HPV9 Dose 2 (6 months after Dose 1) HPV9 Dose 3 (4 months after Dose 2) As per the Ministry of Health guidelines, based on a child s age and the intervals between the doses, the total number of HPV9 doses to be given will vary. The details for these dosage variations are given below: 1. If the child receives the first two doses of the HPV9 vaccine, at least 5 months apart, then they do not have to receive a third dose of the HPV9 vaccine. In this scenario, the HPV9 Dose 3 can be manually closed off with the Outcome of Closed Not Required. 2. If the child receives the first two doses of the HPV9 vaccine, less than 5 months apart, then they must receive a third dose of the HPV9 vaccine to be fully immunised. 3. If the child does not receive their second HPV9 dose by age 14 years and 364 days, then they must receive the remaining two doses of the HPV9 vaccine to be fully immunised. Copyright Medtech Limited Page 15 of 26

16 The existing standalone vaccination schedule of HPV9 Vaccine Schedule 9-14 yrs will be available to cater to the 9 14 year age group. This schedule can be used under the following circumstance: Children who are on an older immunisation schedule (e.g. 2014, 2011, 2008, etc.) that does not include the HPV9 vaccine doses. Similarly the existing standalone vaccination schedule of HPV9 Vaccine Schedule yrs will be available to cater to the year age group. This schedule can be used under the following circumstances: Children who are on an older immunisation schedule (e.g. 2014, 2011, 2008, etc.) that does not include the HPV9 vaccine doses. If the child has not started the HPV9 Dose 1 vaccine, available under the 2017 Immunisation Schedule by age 15 years, then the practice must use this standalone schedule to complete the required HPV9 doses. Copyright Medtech Limited Page 16 of 26

17 Copyright Medtech Limited Page 17 of 26

18 New High Risk Vaccinations Setup of High Risk Vaccines File Options Recall Screening Vaccine Various new High Risk funded vaccines have been introduced in Medtech Evolution. Vaccine Codes Vaccine Names Purpose PCV13H PCV13 High Risk To be given to high-risk children (not covered by current pneumococcal programme) and high-risk adults HIBHR Hib High Risk To be given to high-risk children and adults MENBHR MenB High Risk To be given to high-risk children and adults during an outbreak of Meningococcal B infection in NZ HEPBHR HepB Paed High Risk To be given to high-risk children and adolescents HEPBAH HepB Adult High Risk To be given to high-risk adults New High Risk Vaccines Patient Immunisations The new High Risk vaccines will cater to high-risk children and adults. These High Risk vaccines will be available for selection via the Single Syringe icon under the Immunisation Schedule tab and the All Immunisations tab. These vaccines will be messaged to NIR irrespective of the patient s age. Copyright Medtech Limited Page 18 of 26

19 Copyright Medtech Limited Page 19 of 26

20 Copyright Medtech Limited Page 20 of 26

21 Copyright Medtech Limited Page 21 of 26

22 Increase in Dosage Interval between 23PPV Vaccines Changes to 23PPV Vaccine-containing Schedules File Options Recall Screening Vaccine Group Patient Immunisations Based on a directive from the Ministry of Health, the dosage interval between the two 23 PPV vaccine doses (Pneum, poly 1 st & Pneum, poly 2 nd ) has been increased from 3 years to 5 years. This has been implemented by updating the Due at Age date or Due from Schedule Start date for all vaccine groups containing the second 23PPV dose. If a patient is already on an immunisation schedule containing the 23PPV vaccine, then the recall period will be amended from 3 years to 5 years for the second dose of 23PPV (Pneum, poly 2 nd vaccine). This change in the dosage intervals between two 23PPV vaccines will affect the following immunisation schedules: Copyright Medtech Limited Page 22 of 26

23 1. Pneum schedule (6W to 6M) Pneum schedule (7M to 11M) Pneum schedule (12M to 21M) Pneum schedule (22M to 47M) Pneum 1 prev PCV (2 to 5Y) Pneum 2 prev PCV (2 to 5Y) Pneum 3 prev PCV (2 to 5Y) Pneum 4 prev PCV (2 to 5Y) Pneum 1 prev 23PPV (2 to 5Y) Pneum schedule (6W to 6M) Pneum schedule (7M to 11M) Pneum schedule (12M to 21M) Pneum schedule (22M to 47M) Pneum 1 prev PCV (2 to 5Y) Pneum 2 prev PCV (2 to 5Y) Pneum 3 prev PCV (2 to 5Y) Pneum 4 prev PCV (2 to 5Y) Pneum 1 prev 23PPV (2 to 5Y) Pneum schedule (6W to 6M) 20. Pneum schedule (7M to 11M) 21. Pneum schedule (12M to 21M) 22. Pneum schedule (22M to 47M) 23. Pneum 1 prev PCV (2 to 5Y) 24. Pneum 2 prev PCV (2 to 5Y) 25. Pneum 3 prev PCV (2 to 5Y) 26. Pneum 4 prev PCV (2 to 5Y) 27. Pneum 1 prev 23PPv (2 to 5Y) Copyright Medtech Limited Page 23 of 26

24 Changes to Valid Alternatives of Tdap-11y Vaccine Addition of new Valid Alternative Vaccine for Tdap-11y Patient Immunisations The Tdap-11y vaccine given to children at age 11 years was missing the IPV vaccine as an Alternative Given selection option. The IPV vaccine has now been added. With the addition of this alternative vaccine, the different Alternative Given selection options available for Tdap-11y vaccine are as follows: 1. TT11y 2. Td11y 3. d11y 4. dtap-ipv 11y 5. IPV misc/11y Copyright Medtech Limited Page 24 of 26

25 Messaging of all Valid Alternatives of Tdap-11y Vaccine to NIR All valid alternative vaccines given for Tdap-11y vaccine will be sent to NIR, irrespective of the patient s Date of Birth (the Age Cohort rule will be disabled for this). Currently, the Age Cohort rule states that immunisation details will be sent to NIR only for those patients whose Date of Birth (DoB) falls after the NIR Go Live date. As part of the change, for a patient who receives one of the valid alternative vaccines for Tdap-11y vaccine, the vaccine details will be sent to NIR even if the patient s DoB falls before the NIR Go Live date. Copyright Medtech Limited Page 25 of 26

26 General Changes Medtech Evolution Immunisation Audit Report Report Immunisations MTEvolution IMM Audit The Medtech Evolution Immunisation Audit Report has been updated to include the new 2017 Childhood Immunisation Schedule vaccines. NIR Immunisation Audit Report Report Immunisations NIR IMM Audit The NIR Immunisation Audit Report has been updated to include the new 2017 Childhood Immunisation Schedule vaccines. Immunisation Merge Field Setup In/OutBox Outbox Document The Immunisation merge field has been updated to include the new 2017 Immunisation Schedule vaccines. Outbox Document Wizard Module Out Box New Document (Wizard Button) The Immunisations section in the More tab of the Out Box Document Wizard has been updated to include the new vaccine codes for the 2017 Immunisation Schedules. Provider Inbox Vaccine Update Messages Module Inbox Provider Inbox The Provider Inbox display for Immunisation Update messages has been updated to ensure correct formatting and display of 2017 Immunisation Schedule vaccines, when importing these vaccines for different patients. For further information or any other queries, please contact Medtech Support via: Medtech Evolution application [Help Contact Support] Online chat: Phone: MEDTECH ( ) Copyright Medtech Limited Page 26 of 26